Document:

Amended and Restated Employment Agreement (Daniel E. Greenleaf)

 Exhibit 10.10 

AMENDED AND RESTATED 

EXECUTIVE EMPLOYMENT AGREEMENT 

This Amended and Restated Executive Employment Agreement (this “Agreement”) is entered into by and between Apria Healthcare
Group Inc., a Delaware corporation (“Apria”) (the “Company”), and Daniel E. Greenleaf (the “Executive”) on October 24, 2008 and effective as of April 7, 2008 (the “Effective Date”).

 RECITALS 

A. It is the desire of the Company to retain the services of the Executive and to recognize the Executive’s contribution to the
Company during the course of his employment. 
 B. The Company and the Executive wish to set forth certain terms and conditions
of the Executive’s employment. 
 C. The Company wishes to provide to the Executive certain benefits in the event that his
employment is terminated by the Company without Cause (as defined below) or in the event that he terminates employment for Good Reason (as defined below), in order to encourage the Executive’s performance and continued commitment to the
Company. 
 D. This Agreement amends and restates in its entirety that certain Executive Employment Agreement by and between the
Company and the Executive dated June 18, 2008 (the “Prior Employment Agreement”). 
 NOW, THEREFORE, in
consideration of the foregoing and of the respective covenants and agreements set forth below, the parties hereto agree as follows: 

1. Term; Positions and Duties. 

(a) Term. The Company hereby agrees to employ the Executive and the Executive hereby agrees to accept such employment, upon the
terms and conditions hereinafter set forth. The term of the employment shall commence on the Effective Date and will continue until the termination of the Executive’s employment by reason of his written resignation, termination by the Company
for any reason by written notice of termination, or death (the “Period of Employment”). The Executive’s employment may be terminated at any time by written notice from the Executive to the Company or from the Company to the Executive,
in the manner provided in Section 6 hereof. 
 (b) Position and Duties. The Executive shall serve as President of
Coram, Inc. (“Coram”), with direct reporting responsibility to the Chief Executive Officer of the Company. Subject to the terms and conditions set forth further herein, the Executive shall undertake such duties and have such authority for
the Company and/or Coram as the Company, through its Chief Executive Officer, shall assign to the Executive from time to time in the Company’s sole and absolute discretion; provided such duties and responsibilities are the types of duties and
responsibilities that would ordinarily be assigned to a person with employment experience and position comparable to that of the Executive and are consistent with the policies, procedures and guidelines of the Company, applicable laws and this
Agreement. The Executive agrees to devote substantially all of his working time and efforts to the business and affairs of the Company and Coram. The Executive further agrees that he shall not undertake any outside

  

 1 

 
activities which create a conflict of interest with his duties to the Company and Coram, or which, in the judgment of the Chief Executive Officer or Board of Directors of the Company, interfere
with the performance of the Executive’s duties to the Company and Coram. The Executive agrees that he shall not be entitled to any additional compensation (other than the compensation from the Company expressly provided for in this Agreement)
for his services to Coram. 
 2. Compensation and Benefits. 

(a) Salary. During the Period of Employment, the Company shall pay to the Executive a base salary at the rate of $475,000 per
year, in accordance with its regular practices and policies. The Company may increase the Executive’s salary from time to time. 

(b) Bonus. During the Period of Employment, the Executive shall be eligible to participate in the Company’s Executive Bonus
Plan, or such other bonus plans applicable to the Executive’s position as in effect from time to time. For 2008, the Executive’s target aggregate bonus opportunity under the Executive Bonus Plan shall be 100% of the Executive’s
annualized rate of base salary as set forth in Section 2(a) above, prorated from April 7, 2008. The actual amount of the bonus the Executive earns for 2008 shall be based on the level of achievement of the applicable performance criteria
set forth in Schedule A to the Executive Bonus Plan, a copy of which is attached hereto as Exhibit A. As also specified in Schedule A attached to the Executive Bonus Plan, the Executive shall be eligible for a maximum bonus of 150% of the
Executive’s salary if the budgeted targets for net revenue, operating income and free cash flow set for Apria are achieved at maximum levels. For 2008, the Executive shall receive a minimum guaranteed bonus payment of 25% of the
Executive’s annualized rate of base salary as set forth in Section 2(a) above, prorated from April 1, 2008. Any bonus paid to the Executive shall be paid at the time and in the form and manner provided under the terms of the plan
pursuant to which it was earned. 
 (c) Equity Awards. As of the Effective Date and subject to the Executive’s
execution effective as of the Effective Date of that certain Non-competition and Non-solicitation Agreement attached hereto as Exhibit B (the “Non-competition Agreement”), the Company shall grant to the Executive (i) an award
of 40,000 restricted stock units (“RSUs”) that represent shares of Apria common stock on a one-for-one basis that vests and is paid in three equal annual installments over the three year period beginning on the first anniversary of the
Effective Date and each anniversary thereafter until the award is fully vested and paid, subject to the Executive’s continued employment with the Company through each vesting date, and (ii) stock appreciation right (“SARs”) with
respect to 300,000 shares of Apria common stock that vest in equal annual installments over the four year period beginning on the first anniversary of the Effective Date and each anniversary of the Effective Date thereafter until the SAR is fully
vested, subject to the Executive’s continued employment with the Company through each vesting date. The base price of the SARs shall be the closing price on the New York Stock Exchange on the Effective Date. The Executive acknowledges and
agrees that he is subject to the Apria Stock Ownership Requirements for Senior Executive Officers, in the form attached hereto as Exhibit C. The Executive shall be eligible for future grants of RSUs, SARs and other equity-based awards under
Apria’s 2003 Performance Incentive Plan, or such other equity compensation plan as may be in effect from time to time. The Company agrees that the agreements evidencing the equity awards described in this Section 2(c) shall provide that
the term “Good Reason” shall have the meaning set forth in Section 3(e) hereof. 
  

 2 

 (d) Other Employee Benefits. During the Period of Employment, the Executive shall be
entitled to participate in the Company’s group life, health and disability insurance plans, the Company’s 401(k) Savings Plan as well as the Senior Executive Medical and Dental Programs, subject in all respects to the terms and conditions
of those plans and programs. In addition, the Executive shall be entitled to participate in all other employee benefit plans, programs and arrangements of the Company (including, without limitation, annual bonus, equity compensation, welfare,
fringe, retirement, savings, vacation, deferred compensation and any other plans, programs and arrangements) applicable to senior executives or employees of the Company generally, in accordance with the terms of such plans, programs or arrangements
as they shall be in effect from time to time during the term of the Executive’s employment; provided, however, that nothing herein shall entitle the Executive to any specific awards under the Company’s equity compensation plans or other
discretionary employee benefit plans. Subject to the terms and conditions set forth further herein, the parties to this Agreement recognize that the Company may terminate or modify such plans, programs or arrangements at any time without the consent
of the Executive. 
 (e) Relocation. The Executive’s principal work location shall be at Coram’s headquarters
in Denver, Colorado. The Executive acknowledges and agrees that it is a condition of his employment with the Company that the Executive relocates to the Denver, Colorado area. In connection with the Executive’s relocation, the Company shall
provide the Executive with executive-management relocation benefits such that the Executive will be reimbursed for approved reasonable expenses associated with the Executive’s relocation, including realtor and closing cost fees for the
Executive’s New Jersey and Denver, Colorado area residences, movement of personal household items, shipment of two personal vehicles and temporary living and storage expenses. Additionally, the Company shall reimburse the Executive for
reasonable expenses for up to five house hunting trips for the Executive and his spouse (with such travel arrangements to be made through the Company’s travel department). 

If the Executive’s New Jersey residence becomes vacant and remains unsold, the Company will reimburse the Executive an amount equal to the greater
of $7,000 gross or $4,500 net per month, for up to six months, to cover the residence’s carrying costs. In addition, during the period prior to the sale of the New Jersey residence, if the Executive incurs additional temporary indebtedness to
fund the equity portion of the purchase price for the Executive’s Denver, Colorado area residence, the Company shall also reimburse the Executive for up to a total of $30,000 of the interest costs associated with that additional indebtedness.
If the Executive’s New Jersey residence does not sell within six months, the Company and the Executive shall negotiate in good faith other possible assistance arrangements. 

Any reimbursements to the Executive pursuant to this Section 2(e) shall be made in accordance with the Company’s reimbursement policies as they
may be in effect from time to time and in all events shall be made not later than the end of the calendar year following the year in which the related expense was incurred. 

(f) Vacation and Fringe Benefits. The Executive shall be entitled to a minimum of 20 days of vacation annually, to be available
and prorated monthly during the terms of this Agreement and otherwise to be consistent with the vacation policy and practice applicable to other senior executives of the Company. 

(g) Expenses. During the Period of Employment, the Executive shall be entitled to receive reimbursement for all reasonable and
customary expenses incurred by the 
  

 3 

 
Executive in performing services for the Company in accordance with the Company’s reimbursement policies as they may be in effect from time to time. The parties to this Agreement recognize
that such policies may be amended and/or terminated by the Company at any time without the consent of the Executive. In all events, any reimbursement made to the Executive pursuant to this Section 2(g) shall be made not later than the end of
the calendar year following the year in which the related expense was incurred, and the amount of expenses eligible for reimbursement during any calendar year will not affect the amount of expenses eligible for reimbursement during any subsequent
calendar year. 
 3. Grounds for Termination. Subject to the terms and conditions set forth further herein, the
Executive’s employment may be terminated by the Company or the Executive at any time, for any reason or no reason, with or without Cause or Good Reason (as such terms are defined below). The Executive’s employment may end for any one of
the following reasons: 
 (a) Without Cause or Without Good Reason. The Executive or the Company may terminate the
Executive’s employment at any time, without Cause (in the case of the Company) or without Good Reason (in the case of the Executive), by giving the other party to this Agreement at least thirty (30) days advance written notice of such
termination. 
 (b) Death. The Executive’s employment hereunder shall terminate upon his death. 

(c) Disability. If the Company determines in good faith that the Executive has incurred a Disability (as defined below), it may
give the Executive written notice in accordance with Section 6 of this Agreement of its intention to terminate the Executive’s employment. In such event, the Executive’s employment shall terminate effective on the 30th day following
receipt of such notice by the Executive; provided that, within the 30-day following receipt, the Executive shall not have returned to full-time performance of his duties. For purposes of this Agreement, “Disability” shall mean the
Executive’s incapacity due to physical or mental impairment which substantially limits a major life activity and which renders the Executive unable to perform the essential functions of his position on a full-time basis for the entire period of
six (6) consecutive months, even with reasonable accommodation that does not impose an undue hardship on the Company. 

(d) Cause. The Company may terminate the Executive’s employment for Cause. For purposes of this Agreement (except as set
forth below), “Cause” shall mean that the Board of Directors of the Company, acting in good faith based upon the information then known to the Company, determines that the Executive has (i) engaged in or committed willful misconduct;
(ii) engaged in or committed theft, fraud or other conduct constituting a felony (other than traffic related offenses or as a result of vicarious liability); (iii) refused or demonstrated an unwillingness to substantially perform his
duties for a 30-day period after written demand for substantial performance that refers to this Section 3(d) and is delivered by the Company that specifically identifies the manner in which the Company believes the Executive has not
substantially performed his duties for the Company or Coram; (iv) refused or demonstrated an unwillingness to reasonably cooperate in good faith with any Company, Coram or government investigation or provide testimony therein (other than such
failure resulting from the Executive’s disability); (v) engaged in or committed any willful act that is likely to and which does in fact have the effect of injuring the reputation or business of the Company or Coram; (vi) willfully
violated his fiduciary duty or his duty of loyalty to the Company or Coram or the Company’s Code of Ethical Business Conduct in any material respect; (vii) used alcohol 

 

 4 

 
or drugs (other than drugs prescribed to the Executive by a physician and used by the Executive for their intended purpose for which they had been prescribed) in a manner which materially and
repeatedly interferes with the performance of his duties hereunder or which has the effect of materially injuring the reputation or business of the Company or Coram; or (viii) engaged in or committed a material breach of this Agreement for a
30-day period after written notification is delivered by the Company that specifically refers to this Section 3(d) and identifies the manner in which the Company believes the Executive has materially breached this Agreement. For purposes of the
above clauses (i), (v) and (vi) of this Section 3(d), no act, or failure to act, on the Executive’s part shall be considered willful unless done or omitted to be done, by him not in good faith or without reasonable belief that
his action or omission was in the best interest of the Company. Notwithstanding anything herein to the contrary, for purposes of any termination of employment that occurs within the period that (i) begins with the first to occur of (1) the
initial public announcement of a Change of Control (as defined below), or (2) the 90th day preceding a Change of Control and (ii) ends two years following such Change of Control, “Cause” shall instead mean only the occurrence of
either or both of the following: (A) the Executive’s conviction for committing an act of fraud, embezzlement, theft, or other act constituting a felony (other than traffic related offenses or as a result of vicarious liability); or
(B) the willful engaging by the Executive in misconduct that is significantly injurious to the Company or Coram. For purposes of the above clause (B) of this Section 3(d), no act, or failure to act, on the Executive’s part shall
be considered willful unless done or omitted to be done, by him not in good faith or without reasonable belief that his action or omission was in the best interest of the Company. Notwithstanding the foregoing, the Executive shall not be deemed to
have been terminated for Cause without delivery to the Executive of a notice of termination signed by the Company’s Chief Executive Officer or Chairman of the Board stating that in the good faith opinion of such officer signing the notice, the
Executive has engaged in or committed conduct of the nature described in this Section 3(d), specifying the particulars thereof in detail and, further, providing the Executive a reasonable opportunity to respond. 

(e) Resignation for Good Reason. The Executive may resign on account of Good Reason (as defined below). 

4. Payments upon Termination. 

(a) Without Cause or With Good Reason. In the event that the Executive’s employment is terminated by the Company for any
reason other than death, Disability or Cause as defined in Sections 3(b), (c) and (d) of this Agreement, or in the event that the Executive terminates his employment hereunder with Good Reason as defined in Section 4(c) of this
Agreement, the Executive shall be entitled to receive severance pay in an aggregate amount equal to 200% of his Annual Compensation, which shall be paid, subject to Section 11(b), in periodic installments in accordance with the Company’s
customary payroll practices over a period of twenty-four (24) months, less any amounts required to be withheld by applicable law, with the first such installment payable within ten (10) business days following the date the release referred
to below in this Section 4(a) becomes irrevocable under applicable law and in all events not later than the end of the month following the month in which the Executive’s Separation from Service (as such term is defined in
Section 4(g)) occurs; provided, however, that any such payment shall be contingent upon the Executive’s execution and delivery to the Company within 21 days of the termination of his employment (or such longer period as may be required
under applicable law) of a valid release of all claims the Executive may have against the Company in the form attached hereto as Exhibit D (which may be modified only to the extent necessary to reflect developments in applicable law that
would jeopardize enforceability of such 
  

 5 

 
release unless the modifications are not made), and not revoking such release within any revocation period provided under applicable law, and continued compliance with the restrictive covenants
described in Sections 7, 8 and 9 below; and provided, further, that, if the Executive provides such release of claims, in no event shall the Executive be entitled to payment pursuant to this Section 4(a) of less than $5,000, which amount
the parties agree is good and adequate consideration, in and of itself, for such release. The Company will also pay to the Executive any Accrued Obligations (as defined in Section 4(f) below). 

(b) Annual Compensation. For purposes of this Section 4, the term “Annual Compensation” means an amount equal to
the Executive’s annual base salary at the rate in effect on the date on which the Executive received or gave written notice of his termination, plus the sum of (i) an amount equal to the average of the annual bonuses with respect to the
Company’s two (2) most recently completed fiscal years, if any, determined to be payable and/or paid to the Executive under the Company’s the Executive Bonus Plan (or comparable bonus plan) prior to such notice of termination, and
(ii) an amount determined by the Company from time to time in its sole discretion to be equal to the annual cost for the Executive of obtaining medical, dental and vision insurance under COBRA, which annual amount is hereby initially estimated
to be $20,000. For purposes of calculating the Executive’s Annual Compensation under this Agreement in the event the Executive has been employed by the Company for a period which does not include two full annual bonus cycles or for which the
Company did not maintain a bonus plan, the average of the annual bonuses described in clause (i) above shall be deemed to be equal to (A) if clause (B) below does not apply, 100% of the Executive’s base salary for the year of
termination or (B) in the event that the Executive has been employed for a period which includes one (but not two) full annual bonus cycles prior to the termination of employment, the average of the earned annual bonus for the full bonus cycle
during the Executive’s employment plus an amount equal to 100% of the Executive’s base salary for the year of termination. 

(c) Good Reason. For purposes of this Agreement, the term “Good Reason” means the occurrence of any of the following,
without the written consent of the Executive, unless such event is rescinded within ten (10) business days after the Executive notifies the Company that he objects thereto: 

 

	 	(i)	any reduction in the Executive’s combined annual base salary and target level bonus percentage, except for a general one-time “across-the-board” salary
reduction not exceeding ten percent (10%) which is imposed simultaneously on all executive officers of the Company; or 

  

	 	(ii)	the Company requires the Executive to be based at an office location which will result in an increase of more than thirty (30) miles in the Executive’s
one-way commute, except in connection with a relocation of the Company’s principal executive offices and except for the relocation contemplated by Section 2(e); 

 

	 	(iii)	the Company does not permit the Executive to continue to serve as President of Coram or another mutually acceptable senior executive position; 

provided, however, that “Good Reason” shall cease to exist for an event on the
60th day following the earlier of the Company’s
written notice of the change to the Executive or the Executive’s becoming aware thereof, unless the Executive has given the Company written notice of his objection thereto prior to such date. 

 

 6 

 Notwithstanding anything herein to the contrary, for purposes of any termination of employment that occurs
within the period that (A) begins with the first to occur of (1) the initial public announcement of a Change of Control (as defined below), or (2) the 90th day preceding a Change of Control and (B) ends two years following such
Change of Control, “Good Reason” shall instead mean, without the Executive’s express written consent, the occurrence of any one or more of the following: 
  

	 	(i)	a material reduction in the nature, status or scope of the Executive’s authorities, duties, and/or responsibilities (when such authorities, duties, and/or
responsibilities are viewed in the aggregate) from their level in effect on the day immediately prior to the Change of Control (provided, however, that neither of (A) a change in the Executive’s title or reporting relationships, nor
(B) an adjustment in the nature of the Executive’s duties and responsibilities that in either case does not remove from him the authority with respect to the Company’s functional area, employees or products and services that the
Executive had immediately prior to such change or adjustment shall constitute “Good Reason”); 

  

	 	(ii)	a reduction in the Executive’s base salary from its highest level in effect at any point in the three months preceding the Change of Control or a significant
reduction in the Executive’s aggregate incentive opportunities under the Company’s short and/or long-term incentive programs and/or bonus plans, as such opportunities exist immediately prior to the Change of Control;

  

	 	(iii)	the failure of the Company to maintain the Executive’s relative level of coverage and accruals (as compared to other Company executives) under the Company’s
employee benefit and/or retirement plans, policies, practices, or arrangements in which the Executive participates immediately prior the Change of Control (both in terms of the amount of benefits provided, and amounts accrued) (for this purpose, the
Company may eliminate and/or modify existing programs and coverage levels without the Executive’s consent; provided, however, that the Executive’s level of coverage under all such programs must be at least as great as is provided to
executives who have the same or lesser levels of reporting responsibilities within the Company’s organization); 

  

	 	(iv)	the Executive is informed by the Company that his principal place of employment for the Company will be relocated to a location that will result in an increase of more
than thirty (30) miles in the Executive’s one-way commute (as compared to the Executive’s one-way commute prior to the Change of Control); or 

  

 7 

	 	(v)	the Company’s not permitting the Executive to continue to serve as President of Coram or another mutually acceptable senior executive position.

 (d) Release of all Claims. The Executive understands and agrees that the Company’s obligation to
pay the Executive severance pay under this Agreement is subject to the Executive’s execution of a valid written waiver and release of all claims which the Executive may have against the Company and/or its successors in the form attached hereto
as Exhibit D. 
 (e) No Mitigation or Offset. Notwithstanding anything herein to the contrary, the amount of any
payment or benefit provided for in this Section 4 shall not be reduced, offset or subject to recovery by the Company or any of its subsidiaries or affiliates by reason of any compensation earned by the Executive as the result of employment by
another employer after the Executive’s employment with the Company terminates for any reason. In addition, the Executive shall be under no obligation to seek other employment or to take any other actions to mitigate the amounts payable under
this Section 4. 
 (f) Death, Disability, Cause or Without Good Reason. In the event that the Executive’s
employment is terminated due to death, disability, Cause or by the Executive without Good Reason, the Company shall not be obligated to pay the Executive any amount other than accrued and unpaid vacation, reimbursement for business expenses incurred
prior to his termination and in compliance with the Company’s reimbursement policies, any unpaid salary for days worked prior to the termination, all other amounts accrued and earned by the Executive through the date of termination under the
then existing plans and policies of the Company, and any amounts owing in respect of the Company’s indemnification obligations to the Executive (collectively, the “Accrued Obligations”). 

(g) Separation from Service. As used herein, a “Separation from Service” occurs when the Executive dies, retires, or
otherwise has a termination of employment with the Company that constitutes a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h)(1), without regard to the optional alternative definitions available
thereunder. 
 (h) Change of Control. For purposes of this Agreement, a “Change of Control” shall, unless
otherwise determined by the Board of Directors of the Company or Compensation Committee thereof prior to the consummation of the Change of Control, be deemed to have occurred if: 

 

	 	(i)	any “person,” as such term is used in Sections 13(d)and 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “1934 Act”) is, becomes or
enters a contract to become, the “beneficial owner,” as such term is used in Rule 13d-3 promulgated under the 1934 Act, directly or indirectly, of securities representing twenty-five percent (25%) or more of the voting common stock of
the Company; 

  

	 	(ii)	 all or substantially all of the business or assets of the Company are disposed of, or a contract is entered to dispose of all of the business of the
Company pursuant to a merger, consolidation other transaction in which (a) the Company is not the surviving parent company or (b) the stockholders of the Company prior to the

  

 8 

	 	 
transaction do not continue to own at least sixty percent (60%) of the surviving parent company in substantially the same proportions as their ownership immediately prior to such
transaction; 

  

	 	(iii)	the following individuals cease for any reason to constitute a majority of the number of directors then serving: individuals who, on the Effective Date, constitute the
Board of Directors of Apria and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including but not limited to a consent solicitation, relating to the election
of directors of the Company) whose appointment or election to the Board of Directors of Apria or nomination for election by the Company’s stockholders was approved or recommended by a vote of at least two-thirds (2/3) of the directors then
still in office who either were directors on the Effective Date or whose appointment, election or nomination for election was previously so approved or recommended; or 

 

	 	(iv)	the Company is materially or completely liquidated. 

Notwithstanding clause (i) above, a “Change of Control” shall not be deemed to have occurred solely because a person shall be, become or
enter into a contract to become the beneficial owner of 25% or more, but less than 40%, of the voting common stock of the Company, if and for so long as such person is bound by, and in compliance with, a contract with the Company providing that such
person may not nominate, vote for, or select more than a minority of the directors of the Company. The exception provided by the preceding sentence shall cease to apply with respect to any person upon expiration, waiver, or non-compliance with any
such contract, by which such person was bound. 
 (i) In the event that at any time following a Change of Control the Executive
initiates arbitration pursuant to Section 15 to enforce his rights to any payments under Section 4, or the Company seeks to deny, dispute or reduce any such payments for any reason, then: 

 

	 	(i)	the burden of proving that the Executive is not entitled to such payments shall be on the Company; 

 

	 	(ii)	 the Company shall pay all expenses incurred by the Executive in prosecuting or defending any such proceeding as they are incurred by the Executive in
advance of the final disposition of such dispute, together with any tax liability incurred by the Executive in connection with the receipt of such amounts (any such payment to be made within 30 days following Executive’s submission of customary
supporting documentation to the Company and in all events Executive shall submit such supporting documentation to the Company not later than six months after the year in which such expense was incurred, and with respect to any expenses, the amount
of expenses eligible for reimbursement during the Executive’s taxable year may not affect the amount of expenses eligible for reimbursement in any other taxable year); provided, however, that the payment of such expenses incurred in advance of

  

 9 

	 	 
the final disposition of such proceeding shall be made only upon delivery to the Company of an undertaking, by or on behalf of the Executive, to repay all amounts so advanced to the extent the
arbitrator in such proceeding affirmatively determines that the Company is the prevailing party, taking into account all claims made by any such party to such proceeding; and 

 

	 	(iii)	all such payments or benefits described in this Agreement shall continue to be made or provided on the dates provided herein as if all assertions or claims made by the
Executive are accurate without any offsets, claims or charges of any kind whatsoever being asserted by the Company, except in the event a final determination pursuant to the arbitration provisions of Section 15 has been rendered and such
determination provides that the Company is entitled to assert any such offset, claim or charge against the Executive, in which event any such offset, if applicable, shall be in compliance with Section 409A of the Internal Revenue Code of 1986,
as amended (the “Code”). 

 5. Successors; Binding Agreement. 

(a) The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company, to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.
Failure of the Company to obtain such assumption and agreement prior to the effectiveness of any such succession shall be a breach of this Agreement and shall entitle the Executive to compensation from the Company in the same amount and on the same
terms as he would be entitled to hereunder if he terminated his employment for Good Reason, except that for purposes of implementing the foregoing, the date on which any such succession becomes effective shall be deemed the date of termination. As
used in this Agreement, “Company” shall mean the Company as herein before defined and any successor to its business and/or assets as aforesaid which executes and delivers the agreement provided for in this Section 5 or which otherwise
becomes bound by all the terms and provisions of this Agreement by operation of law. 
 (b) This Agreement and all rights of the
Executive hereunder shall inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrator, successors, heirs, distributees, devisees and legatees. If the Executive should die while any
amounts would still be payable to him hereunder if he had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the Executive’s devisee, legatee, or other designee
or, if there be no such designee, to the Executive’s estate. 
  

 10 

 6. Notices. For the purposes of this Agreement, notices, demands and all other
communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered personally, by telecopy, email or other form of written electronic transmission, by overnight courier or by registered or
certified mail, postage prepaid, or mailed by United States certified or registered mail, return receipt requested, postage prepaid, addressed as follows: 

If to the Executive: 

Daniel E. Greenleaf 

If to the Company: 

Apria Healthcare Group Inc. 

26220 Enterprise Court 

Lake Forest, California 92630 

Attention: Chief Executive Officer 

With a copy to the attention of the Company’s Sr. Vice President, Human Resources or to such other address as either party may have furnished to the
other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt. 
 7.
Antisolicitation. The Executive promises and agrees that, during the period of his employment by the Company and for a period of two years thereafter, he will not influence or attempt to influence customers or patients of the Company or any
of its present or future subsidiaries or affiliates, either directly or indirectly, to divert their business to any individual, partnership, firm, corporation or other entity then in competition with the business of the Company, or any subsidiary or
affiliate of the Company, where the identity of the customer or patient, or any information concerning the relationship between the customer or patient and the Company, is a trade secret or other Confidential Material (as defined below). 

8. Soliciting Employees. The Executive promises and agrees that, for a period of two years following termination of his
employment, he will not, directly or indirectly, solicit any of the Company employees who earned annually $50,000 or more as a Company employee during the last six months of his own employment, or facilitate the hiring of any such employee, to work
for any other business, individual, partnership, firm, corporation, or other entity. 
 9. Confidential Information.

 (a) The Executive, in the performance of his duties on behalf of the Company, shall have access to, receive and be entrusted
with confidential information, including but not limited to systems technology, field operations, reimbursement, development, marketing, organizational, financial, management, administrative, clinical, customer, distribution and sales information,
data, specifications and processes presently owned or at any time in the future developed, by the Company or its agents or consultants, or used presently or at any time in the future in the course of its business that is not otherwise part of the
public domain (collectively, the “Confidential Material”). All such Confidential Material is considered secret and will be available to the Executive in confidence. Except in the performance of duties on behalf of the Company, the
Executive shall not, directly or indirectly for any reason whatsoever, disclose or 
  

 11 

 
use any such Confidential Material, unless such Confidential Material ceases (through no fault of the Executive’s) to be confidential because it has become part of the public domain. All
records, files, drawings, documents, notes, disks, diskettes, tapes, magnetic media, photographs, equipment and other tangible items, wherever located, relating in any way to the Confidential Material or otherwise to the Company’s business,
which the Executive prepares, uses or encounters during the course of his employment, shall be and remain the Company’s sole and exclusive property and shall be included in the Confidential Material. Upon termination of this Agreement by any
means, or whenever requested by the Company, the Executive shall promptly deliver to the Company any and all of the Confidential Material, not previously delivered to the Company, that may be or at any previous time has been in the Executive’s
possession or under the Executive’s control. 
 (b) The Executive hereby acknowledges that the sale or unauthorized use or
disclosure of any of the Company’s Confidential Material by any means whatsoever and at any time before, during or after the Executive’s employment with the Company shall constitute unfair competition. The Executive agrees he shall not
engage in unfair competition either during the time employed by the Company or any time thereafter. 
 (c) The Executive
promises and agrees that for a period of one year following termination of his employment, he will not, other than as required by law or by order of a court or other competent authority, make or publish, or cause any other person to make or publish,
any statement that is disparaging or that reflects negatively upon the Company, or that is or reasonably would be expected to be damaging to the reputation of the Company. The Company promises and agrees that it will use its best efforts to not,
other than as required by law or by order of a court or other competent authority, make or publish, or cause any other person to make or publish, any statement that is disparaging or that reflects negatively upon the Executive, or that is or
reasonably would be expected to be damaging to the reputation of the Executive. 
 10. Parachute Limitation. 

 

	 	(i)	 Notwithstanding any other provision of this Agreement, in the event that any amount or benefit that may be paid or otherwise provided to or in respect
of the Executive by or on behalf of the Company or any affiliate, whether pursuant to this Agreement or otherwise (collectively, “Covered Payments”), is or may become subject to the tax imposed under Section 4999 of the Code (or any
successor provision or any comparable provision of state, local or foreign law) (“Excise Tax”), then the portion of the Covered Payments that would be treated as “parachute payments” under Code Section 280G (“Covered
Parachute Payments”) shall be reduced so that the Covered Parachute Payments, in the aggregate, are reduced to the Safe Harbor Amount (as defined below); provided that such reduction to the Covered Payments shall be made only if the total
after-tax benefit to the Executive is greater after giving effect to such reduction than if no such reduction had been made. For purposes of this Agreement, the term “Safe Harbor Amount” means the largest portion of the Covered Payments
that would result in no portion of the Covered Payments being subject to the Excise Tax. In the event that it is determined that the amount of any Covered Payments will be reduced in

  

 12 

	 	 
accordance with this Section 10, the Covered Payments shall be reduced on a nondiscretionary basis in such a way as to minimize the reduction in the economic value deliverable to the
Executive. Where more than one payment has the same value for this purpose and they are payable at different times they will be reduced on a pro rata basis. 

 

	 	(ii)	The determination of (i) whether an event described in Section 280G(b)(2)(A)(i) of the Code has occurred, (ii) the value of any Covered Parachute
Payments and the Safe Harbor Amount, (iii) whether any reduction in the Covered Payments is required under Section 10(a), and (iv) the amount of any such reduction, shall be made initially by an accounting firm selected by the
Compensation Committee of the Board of Directors (as constituted prior to the occurrence of any Change of Control), or, if no such firm is selected, by the independent compensation consulting firm retained by the Compensation Committee prior to any
Change of Control to provide consulting advice to the Compensation Committee (the “Accountants”). For purposes of making the calculations required by this Section 10, the Accountants may make reasonable assumptions and approximations
concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of the Code, and other applicable legal authority. The Company and the Executive shall furnish to the Accountants such information and
documents as the Accountants may reasonably request in order to make a determination under this Section 10. The Company shall bear and be solely responsible for all costs the Accountants may reasonably incur in connection with any calculations
contemplated by this Section 10. 

  

	 	(iii)	If it is determined that a reduction in payments is required pursuant to Section 10(a) and, notwithstanding any prior reduction described in this Section 10,
the Internal Revenue Service (the “IRS”) determines that the Executive is liable for the Excise Tax as a result of the receipt of amounts payable under this Agreement or otherwise as described above, then the Executive shall be obligated
to pay back to the Company, within thirty (30) days after a final IRS determination or in the event that the Executive challenges the final IRS determination, a final judicial determination, a portion of such amounts equal to the
“Repayment Amount”. The Repayment Amount with respect to the payment of benefits shall be, if a reduction in payments is required pursuant to Section 10(a), the smallest such amount as shall be required to be paid to the Company so
that the Executive is not subject to the Excise Tax. 

 11. Section 409A. 

(a) It is intended that any amounts payable under this Agreement and the Company’s and the Executive’s exercise of authority or
discretion hereunder shall comply with Section 409A of the Code (including the Treasury regulations and other published guidance 

 

 13 

 
relating thereto) (“Section 409A”) so as not to subject the Executive to payment of any interest or additional tax imposed under Section 409A. To the extent that any amount
payable under this Agreement would trigger the additional tax imposed by Section 409A, the Agreement shall be construed and interpreted in a manner to avoid such additional tax yet preserve (to the nearest extent reasonably possible) the
intended benefit payable to the Executive. 
 (b) Notwithstanding any provision of this Agreement to the contrary, if the
Executive is a “specified employee” within the meaning of Treasury Regulation Section 1.409A-1(i) as of the date of the Executive’s Separation from Service, and if the deferral of the commencement of any payments or benefits
otherwise payable hereunder for a period of six (6) months following the Executive’s Separation from Service is necessary pursuant to Section 409A of the Code, commencement of any such payments or benefits shall be delayed as required
by Section 409A of the Code. Any amounts otherwise payable to the Executive upon or in the six (6) month period following the Executive’s Separation from Service that are not so paid by reason of this Section 11(b) shall be paid
as soon as practicable (and in all events within thirty (30) days) after the date that is six (6) months after the Executive’s Separation from Service (or, if earlier, as soon as practicable, and in all events within thirty
(30) days, after the date of the Executive’s death), and any such payments shall be increased by an amount equal to interest on such payments for the period commencing with the date such payment would have otherwise been made but for this
Section 11(b) (the “Original Payment Date”) and ending on the date such payment is actually made, at an interest rate equal to the prime rate in effect as of the Original Payment Date plus one point (for this purpose, the prime rate
will be based on the rate published from time to time in The Wall Street Journal). The provisions of this Section 11(b) shall only apply if, and to the extent, required to avoid the imputation of any tax, penalty or interest pursuant to
Section 409A of the Code. 
 (c) Except as otherwise explicitly provided herein, any reimbursements or in-kind benefits
provided hereunder shall be made or provided in accordance with the requirements of Section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during the period of time
specified in this Agreement (or, if no such period is specified, the Executive’s lifetime), (ii) the amount of expenses eligible for reimbursement, or in kind benefits provided, during a calendar year may not affect the expenses eligible
for reimbursement, or in kind benefits to be provided, in any other calendar year, (iii) the reimbursement of an eligible expense will be made no later than the last day of the calendar year following the year in which the expense is incurred,
and (iv) the right to reimbursement or in kind benefits is not subject to liquidation or exchange for another benefit. In addition, any tax gross-up payments provided for herein shall be paid as soon as practicable, but in no event later than
the end of the Executive’s taxable year following the Executive’s taxable year in which he remits the related taxes. Notwithstanding any other provision contained herein, any offset pursuant to the terms this Agreement of amounts payable
to the Executive shall be in accordance with Section 409A of the Code. 
 12. Modification and Waiver. No provisions
of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing signed by the Executive and the Chief Executive Officer of the Company. No waiver by either party hereto at any time of any
breach by the other party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or
subsequent time. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly in this

  

 14 

 
Agreement. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California without regard to its conflicts of law principles.

 13. Severability. The provisions of this Agreement are severable and in the event that a court of competent
jurisdiction determines that any provision of this Agreement is in violation of any law or public policy, in whole or in part, only the portions of this Agreement that violate such law or public policy shall be stricken. All portions of this
Agreement that do not violate any statute or public policy shall not be affected thereby and shall continue in full force and effect. Further, any court order striking any portion of this Agreement shall modify the stricken terms as narrowly as
possible to give as much effect as possible to the intentions of the parties under this Agreement. 
 14. Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument. 

15. Arbitration. Any dispute or controversy arising under or in connection with this Agreement or the Executive’s employment
by the Company shall be settled exclusively by arbitration, conducted before a single neutral arbitrator in accordance with the American Arbitration Association’s National Rules for Resolution of Employment Disputes as then in effect. Judgment
may be entered on the arbitrator’s award in any court having jurisdiction; provided, however, that the Company shall be entitled to seek a restraining order or injunction in any court of competent jurisdiction to prevent any continuation of any
violation of the provisions of Sections 7, 8 or 9 of this Agreement and the Executive hereby consents that such restraining order or injunction may be granted without the necessity of the Company’s posting any bond, and provided, further, that
the Executive shall be entitled to seek specific performance of his right to be paid until the date of employment termination during the pendency of any dispute or controversy arising under or in connection with this Agreement. The Executive
expressly acknowledges and agrees that if the Company has a reasonable good faith belief that he is in violation of any of the restrictive covenants set forth in said Sections 7, 8 or 9, then the Company, following written notice to the
Executive explaining the basis for its belief, may suspend any future payments scheduled to be made pursuant to Section 4, unless and until the Executive establishes to the Company’s reasonable good faith satisfaction that no such
violation has occurred. Each party shall pay its own attorneys’ fees and costs. If any party prevails on a statutory claim which affords attorneys’ fees and costs, the arbitrator may award reasonable attorneys’ fees and/or costs to
the prevailing party. The fees and expenses of the arbitrator and the arbitration shall be borne by the Company. 
 16.
Entire Agreement. This Agreement together with all Exhibits hereto sets forth the entire agreement of the parties hereto in respect of the subject matter contained herein and supersedes all prior agreements, promises, covenants, arrangements,
communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party hereto; and any prior agreement of the parties hereto in respect of the subject matter contained herein (including,
without limitation, the Prior Employment Agreement) is hereby terminated and canceled. 
 IN WITNESS WHEREOF, the parties have
executed this Agreement on the date and year first above written. 
  

 15 

					
	APRIA HEALTHCARE GROUP INC.
		
	By:	 	 /s/ Norman C. Payson

		 	Name:	 	Norman C. Payson, M.D.
		 	Title:	 	Chief Executive Officer
	
	EXECUTIVE
		
	By:	 	 /s/ Daniel E. Greenleaf

		 	Name:	 	Daniel E. Greenleaf

  

 16 

 EXHIBIT A 

APRIA HEALTHCARE GROUP INC. 2008 EXECUTIVE BONUS PLAN 

 EXHIBIT B 

NONCOMPETITION AND NONSOLICITATION AGREEMENT 

 EXHIBIT C 

APRIA HEALTHCARE GROUP INC. STOCK OWNERSHIP REQUIREMENTS FOR 

SENIOR EXECUTIVE OFFICERS 

 EXHIBIT D 

GENERAL RELEASE 

THIS GENERAL RELEASE (this “Release”) is made as of the      day of
                    , 20    , by and between Daniel E. Greenleaf, an individual
(“Executive”), and Apria Healthcare Group Inc., a Delaware corporation (“Apria”). In consideration of the payments and benefits described in paragraph 1 below to be provided to Executive pursuant to that certain
Amended and Restated Executive Employment Agreement, dated October 24, 2008 and effective as of April 7, 2008, to which Executive and Apria are parties (the “Employment Agreement”), the sufficiency of which is acknowledged
hereby, Executive and Apria agree as follows: 
 1. In consideration of Executive’s general release of claims, his
agreements in paragraphs 7, 8 and 9 of the Employment Agreement, and his other promises set forth herein, Apria shall pay to Executive the following amounts: 

(a) a total of $             in severance compensation, subject to
standard withholding for federal and state taxes, which shall be payable in accordance with Apria’s regular payroll procedures in 52 consecutive bi-weekly installments over the 24-month period beginning on
                        , each in the gross amount of
$            ; and 
 (b) all salary amounts earned but not
yet paid, subject to standard withholding for federal and state taxes, payable on or as soon as practicable after
                        . 

2. On or before
                        , Executive shall return to Apria his company-provided laptop computer, cell phone, BlackBerry,
credit cards, electronic fuel card, electronic building access cards and all other property of Apria. He shall not take or copy in any form or manner any financial information, lists of customers, prices, or any other confidential and proprietary
materials or information of Apria. 
 3. Neither this Release nor anything in this Release shall be construed to be or shall be
admissible in any proceeding as evidence of an admission by Apria or Executive of any violation of Apria’s policies or procedures, or state or federal laws or regulations. This Release may be introduced, however, in any proceeding to enforce
the Release. Such introduction shall be pursuant to an order protecting its confidentiality, except insofar as a court declines to enter any such Order. 

4. Except for (i) those obligations created by or arising out of this Release, (ii) any rights Executive may have under stock
option, stock appreciation right and restricted stock unit agreements with Apria and any retirement, 401(k), or similar benefit plans of Apria, and (iii) the continuing right to indemnification as provided by applicable law or in Apria’s
bylaws and articles of incorporation in connection with acts, suits or proceedings by reason of the fact that he was an officer or employee of Apria where the basis of the claims against him consists of acts or omissions taken or made in such
capacity, or any indemnification rights of Executive otherwise 
  

 1 

 
provided pursuant to the Agreement and Plan of Merger among Apria, Sky Acquisition LLC, and Sky Merger Sub Corporation, dated as of June 18, 2008, Executive on behalf of himself, his
descendants, dependents, heirs, executors, administrators, assigns, and successors, and each of them, hereby covenants not to sue and fully releases and discharges Apria, and its predecessors, subsidiaries and affiliates, past and present, and each
of them, as well as its and their trustees, directors, officers, agents, attorneys, insurers, employees, stockholders, representatives, assigns, and successors, past and present, and each of them, hereinafter together and collectively (including
Apria) referred to as the “Apria Releasees,” with respect to and from any and all claims, wages, demands, rights, liens, agreements, contracts, covenants, actions, suits, causes of action, obligations, debts, costs, expenses,
attorneys’ fees, damages, judgments, orders and liabilities of whatever kind or nature in law, equity or otherwise, whether now known or unknown, suspected or unsuspected, and whether or not concealed or hidden, which he now owns or holds or he
has at any time heretofore owned or held as against the Apria Releasees, arising out of or in any way connected with his employment relationship with any Apria Releasee, or his voluntary resignation from employment with the Apria Releasees or any
other transactions, occurrences, actions, omissions, claims, losses, damages or injuries whatsoever, known or unknown, suspected or unsuspected, resulting from any act or omission by or on the part of any Apria Releasee committed or omitted prior to
the date of this Release, including, without limiting the generality of the foregoing, any claim under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the Family and Medical
Leave Act of 1993, the Fair Employment Practices Act, the Equal Pay Laws, the Workers’ Compensation Act, the Family and Medical Leave Act, the Civil Rights Act of 1991, Sections 1981 through 1988 of Title 42 of the United States Code, the
Employee Retirement Income Security Act of 1974, the California Fair Employment and Housing Act, the California Labor Code, the state and federal Worker Adjustment and Retraining Notification Act, the California Business and Professions Code, or any
common law or statutory claim for fraud, wrongful termination, violation of public policy or defamation, or any claim for compensation, severance pay, bonus, sick leave, holiday pay, vacation pay, life insurance, health or medical insurance or any
other fringe benefit, workers’ compensation or disability. 
 Except for those obligations created by or arising out of
this Release, and except as provided below, Apria on behalf of itself and the Apria Releasees (to the extent the matter in question arises on the basis of their relationship to Apria) hereby acknowledges full and complete satisfaction of and
releases and discharges, and covenants not to sue, Executive from and with respect to any and all claims, agreements, obligations, losses, damages, injuries, demands and causes of action, known or unknown, suspected or unsuspected, whether or not
concealed or hidden, arising out of or in any way connected with Executive’s employment relationship with any Apria Releasee or his voluntary resignation from employment with the Apria Releasees, or any other transactions, occurrences, actions,
omissions, claims, losses, damages or injuries whatsoever, known or unknown, suspected or unsuspected, which Apria now owns or holds or has at any time heretofore owned or held as against Executive. 

5. It is the intention of Apria and Executive in executing this Release that the same shall be effective as a bar to each and every
claim, demand and cause of action hereinabove specified. In furtherance of this intention, Apria and Executive hereby expressly waive any and all rights and benefits conferred upon them by the provisions of SECTION 1542 OF THE CALIFORNIA CIVIL CODE
and expressly consent that this Release shall be given full force 
  

 2 

 
and effect according to each and all of its express terms and provisions, including those related to unknown and unsuspected claims, demands and causes of action, if any, as well as those
relating to any other claims, demands and causes of action hereinabove specified. SECTION 1542 provides: 
 “A GENERAL
RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.”

 Apria and Executive, and each of them, acknowledge that either may hereafter discover claims or facts in addition to or
different from those which either or both of them now knows or believes to exist with respect to the subject matter of this Release and which, if known or suspected at the time of executing this Release, may have materially affected this settlement.
Nevertheless, Apria and Executive each hereby waive any right, claim or cause of action that might arise as a result of such different or additional claims or facts. Apria and Executive each acknowledge that it or he understands the significance and
consequence of such release and such specific waiver of SECTION 1542. 
 6. The terms and conditions of this Release shall
remain confidential as between the parties and professional advisers to the parties and neither of them shall disclose them to any other person, except as provided herein or as required by the rules and regulations of the Securities and Exchange
Commission (“SEC”) or as otherwise may be required by law or court order. Without limiting the generality of the foregoing, neither Apria nor Executive will respond to or in any way participate in or contribute to any public discussion
concerning, or in any way relating to, the execution of this Release or the events which led to its execution. Except as provided above with respect to SEC rules and regulations or as otherwise may be required by law or court order, if inquiry is
made of Apria concerning any of the claims released by this Release or relating to Executive’s employment with Apria, Apria shall provide to third parties Executive’s dates of employment with Apria and its predecessors and his job titles
during such employment, in accordance with the normal practices of Apria’s human resources department. 
 7. Executive
expressly acknowledges and agrees that, by entering into this Release, he is waiving any and all rights or claims that may have arisen under the Age Discrimination in Employment Act of 1967, as amended, which have arisen on or before the date of
execution of this Release. Executive further expressly acknowledges that: 
 a. He is hereby advised in writing by this Release
to consult with an attorney before signing this Release; 
 b. He was given a copy of this Release on
                        , and informed that he had 21 days within which to consider this Release, although he is free to
execute this Release anytime within that 21-day period as indicated in Section 18 below; and 
 c. He was informed that he
has seven days following the date of his execution of this Release in which to revoke this Release, which revocation may be effected by 

 

 3 

 
means of a written notice sent to the General Counsel of Apria at Apria’s corporate headquarters, provided that in all events any revocation must be received by Apria during the seven-day
revocation period. 
 d. Apria and Executive agree that this Release will not become effective or enforceable until the
seven-day revocation period has expired without Executive’s having revoked this Release. 
 8. Apria and Executive each
warrant and represent that neither has heretofore assigned or transferred to any person not a party to this Release any released matter or any part or portion thereof and each shall defend, indemnify and hold harmless the other from and against any
claim (including the payment of attorneys’ fees and costs actually incurred whether or not litigation is commenced) based on or in connection with or arising out of any such assignment or transfer made, purported or claimed. 

9. Apria and Executive acknowledge that any employment relationship between them (including with any other Apria Releasee) will terminate
on                         , that they have no further employment relationship except as may arise out of this Release and
that Executive waives any right or claim to reinstatement as an employee of any Apria Releasee and will not seek employment in the future with Apria, unless by mutual consent. Nothing herein shall be construed as voiding Executive’s entitlement
to post-termination payments pursuant to Section 1 above or the Company’s (or any of its affiliates as the case may be) rights pursuant to Sections 7, 8 and 9 of the Employment Agreement. 

10. This Release shall be incorporated into and made a part of the Employment Agreement as of the date hereof. This Release, together
with the Employment Agreement and the Non-competition Agreement (as defined in the Employment Agreement), sets forth the entire agreement and understanding between the parties as to the subject matter hereof and supersedes all prior and
contemporaneous oral and written discussions, agreements and understandings of any kind or nature. This Release shall inure to the benefit of and be binding upon the parties hereto and their respective permitted successors and assigns. This Release
does not, however, affect Executive’s rights under any Apria retirement, 401(k), or similar benefit plan. This Release also does not modify the provisions of any of Executive’s stock options, stock appreciation rights or restricted stock
units. 
 11. If any provision of this Release or the application thereof is held invalid, the invalidity shall not affect the
other provisions or applications of this Release which can be given effect without the invalid provisions or applications and to this end the provisions of this Release are declared to be severable. 

12. This Release has been executed and delivered by Executive within the State of California, and the rights and obligations of the
parties hereunder shall be construed and enforced in accordance with, and governed by, the laws of the State of California without regard to principles of conflict of laws. 

 

 4 

 13. This Release may be executed in counterparts, and each counterpart, when executed, shall
have the efficacy of a signed original. Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose. 

14. Any dispute or controversy between Executive on the one hand, and Apria (or any other Apria Releasee), on the other hand, in any way
arising out of, related to, or connected with this Release or the subject matter hereof, or otherwise in any way arising out of, related to, or connected with Executive’s employment with any Apria Releasee or the termination of Executive’s
employment with any Apria Releasee, shall be submitted for resolution by arbitration in accordance with the provisions of the Employment Agreement. APRIA AND EXECUTIVE ACKNOWLEDGE, UNDERSTAND AND AGREE THAT IN THE EVENT OF A DISPUTE UNDER THIS
RELEASE, EACH PARTY HAS WAIVED ANY RIGHT TO A JURY TRIAL AND A JUDICIAL RESOLUTION OF THE DISPUTE. 
 15. No waiver of any
breach of any term or provision of this Release shall be construed to be, or shall be, a waiver of any other breach of this Release. No waiver shall be binding unless in writing and signed by the party waiving the breach. 

16. In entering this Release, the parties represent that they have relied upon the advice of their attorneys, who are attorneys of their
own choice, and that they have read the Release and have had the opportunity to have the Release explained to them by their attorneys, and that those terms are fully understood and voluntarily accepted by them. 

17. All parties agree to cooperate fully and to execute any and all supplementary documents and to take all additional actions that may
be necessary or appropriate to give full force to the terms and intent of this Release and which are not inconsistent with its terms. 

18. Executive hereby declares as follows: 

I,
                        , hereby acknowledge that I was given 21 days to consider the foregoing Release and voluntarily
chose to sign the Release prior to the expiration of the 21-day period. 
 I have read the foregoing Release and I accept and
agree to the provisions it contains and hereby execute it voluntarily with full understanding of its consequences. 
 I declare
under penalty of perjury under the laws of the State of California that the foregoing is true and correct. 
 [signature page
follows] 
  

 5 

 IN WITNESS WHEREOF, the undersigned have executed and delivered this Release this
     day of                     , 20    . 

 

			
	  

	Daniel E. Greenleaf
	
	APRIA HEALTHCARE GROUP INC.
		
	By:	 	  

		 	[Name]
		 	[Title]

  

 6Amended and Restated Noncompetition Agreement (Karkenny)

 Exhibit 10.11 

AMENDED AND RESTATED NONCOMPETITION AGREEMENT 

This Amended and Restated Noncompetition Agreement (this “Agreement”) is dated as of the 7th day of March, 2007 (the
“Effective Date”) by and between Chris A. Karkenny (the “Executive”) and Apria Healthcare Group Inc. (the “Company”). 

INTRODUCTORY PROVISIONS 

The following provisions are true and correct and constitute the basis for this Agreement: 

 

	A.	Concurrently herewith, the Executive is entering into one or more agreements (herein referred to as “Incentive Compensation Agreements”) with the Company
pursuant to which the Executive, subject to continued employment through the dates therein described and certain other restrictions, is receiving the option to purchase or otherwise receive shares of common stock issued by the Company as well as
certain other benefits and the Executive is now being or may hereafter be offered the opportunity, at the Company’s discretion, to participate in one or incentive compensation or similar plans pursuant to which the Executive will be eligible to
earn additional compensation beyond the Executive’s base salary (hereinafter referred to as “Incentive Compensation Plans”). 

  

	B.	The Executive and the Company are executing this document to express their agreement concerning certain covenants pertaining to the protection of the Company’s
confidential information and trade secrets and its business whereby the Executive agrees to satisfy certain obligations to perform and refrain from performing certain acts during the Executive’s employment with the Company and following the
termination of the Executive’s employment with the Company. 

  

	C.	The Executive and the Company acknowledge and agree that the rights granted to the Executive under the Incentive Compensation Plans and Incentive Compensation
Agreements, as well as the Executive’s continued at-will employment with the Company and access to the Company’s confidential information and trade secrets, Executive’s continued receipt of salary and other remuneration and benefits
associated with that at-will employment, and other good and valuable consideration, constitute adequate and sufficient consideration for the Executive’s entering into this Agreement. 

 

	D.	The Executive and the Company have previously entered into a Noncompetition Agreement dated as of November 13, 2006 (the “Prior Noncompetition Agreement”) and
an Amended and Restated Executive Severance Agreement of even date therewith (the “Severance Agreement”). This Agreement provides for certain payments to the Executive upon certain terminations of employment in connection with Change in
Control (as defined below) from and after the Effective Date and supersedes and negates any and all previous agreements with respect to such payments, including, without limitation, the Prior Noncompetition Agreement; provided, however, that this
sentence shall not apply to any severance benefits to which the Executive may become entitled under the Severance Agreement. 

 NOW, THEREFORE, for the purposes and considerations expressed above, the parties
hereto, intending to be legally bound, agree as follows: 
 1. Confidential Information. 

(a) The Executive acknowledges that, in the performance of the Executive’s duties on behalf of the Company, the
Executive has had and will have access to, has received and will receive, and has been entrusted and will be entrusted with confidential information and trade secrets including but not limited to systems technology, field operations, reimbursement,
development, marketing, organizational, financial, management, administrative, clinical, customer, distribution and sales information, data, specifications and processes owned by the Company or any of its affiliates (collectively, the “Company
Group”), or used presently or at any time in the future in the course of the business of the Company Group that is not otherwise part of the public domain (collectively, the “Confidential Material”). All such Confidential Material is
considered secret and was and will be made available to the Executive in confidence. 
 (b) The Executive hereby
agrees that the Executive shall not at any time (whether during or after the Executive’s employment with the Company), directly or indirectly, other than in the course of the Executive’s duties to the Company, disclose or make available to
any person, firm, corporation, association or other entity for any reason or purpose whatsoever, any Confidential Material; provided, however, that this Section 1(b) shall not apply when (i) disclosure is required by law or by any court, arbitrator,
mediator or administrative or legislative body (including any committee thereof) with apparent jurisdiction to order the Executive to disclose or make available such information (provided, however, that the Executive shall promptly notify the
Company in writing upon receiving a request for such information), or (ii) with respect to any other litigation, arbitration or mediation involving this Agreement, including but not limited to enforcement of this Agreement. The Executive agrees
that, upon termination of the Executive’s employment with the Company, all Confidential Material in the Executive’s possession that is in written, digital or other tangible form (together with all copies or duplicates thereof, including
computer files) shall be returned to the Company and shall not be retained by the Executive or furnished to any third party, in any form except as provided herein; provided, however, that the Executive shall not be obligated to treat as
confidential, or return to the Company copies of any Confidential Material that (x) was publicly known at the time of disclosure to the Executive, (y) becomes publicly known or available thereafter other than by any means in violation of this
Agreement or any other duty owed to the Company by any person or entity, or (z) is lawfully disclosed to the Executive by a third party. 

2. Noncompetition Covenants. 

(a) The Executive acknowledges that the Executive’s employment with a competitor of the Company Group within a
reasonable time following the termination of the Executive’s employment with the Company Group would create a substantial likelihood that the Executive would inevitably disclose or use, to the detriment of the Company Group, Confidential
Material, and that it is essential to the Company Group’s legitimate business interests and also to free and fair competition in the industry within which the Company Group does business, to protect the Company Group’s Confidential
Material from disclosure. 
  

 2 

 (b) The risk of inevitable disclosure is particularly applicable to any such
employment by the Executive with those competitors of the Company Group that are similar in operation, service, missions and markets to the Company Group (“Principal Competitors”). As of the date of this Agreement, the Principal
Competitors are: Lincare Holdings, Inc.; Rotech Healthcare, Inc.; American HomePatient, Inc.; Coram Healthcare Corporation; Option Care, Inc.; Pacific Pulmonary Services Corporation; LifeCare Solutions, Inc.; and the home healthcare businesses of
Air Products & Chemicals, Inc. and Praxair, Inc. and their respective parent, affiliated and subsidiary companies. 

(c) In order avoid the disclosure by the Executive of the Company’s trade secrets or other Confidential Material to
those businesses that could most adversely affect the performance of the Company Group and damage its goodwill, the Executive agrees that, during the period of the Executive’s employment by the Company and for a period of one year following the
date on which the Executive’s employment with the Company Group terminates for any reason (the “Post-Termination Period”), the Executive will not engage, directly or indirectly, in business with or work with or for, whether as an
owner, employee, consultant or otherwise, any Principal Competitor; provided, however, that this restriction shall not prevent the Executive from owning less than 1% of any class of publicly-traded securities (or other equity interests held through
a publicly-traded mutual fund or similar investment) of a Principal Competitor following the termination of the Executive’s employment with the Company. The Executive expressly acknowledges and agrees that the foregoing restriction is
reasonable and necessary in order to protect the Confidential Material of the Company Group. The phrase “engage, directly or indirectly” means engaging or having an interest in, directly or indirectly, as owner, partner, participant of a
joint venture, trustee, proprietor, shareholder, member, manager, director, officer, employee, independent contractor, capital investor, lender, consultant, advisor or similar capacity. 

3. Nonsolicitation Covenants. 

(a) During the term of the Executive’s employment with the Company and during the Post-Termination Period, the
Executive will not, directly or indirectly, individually or as a consultant to, or as an employee, officer, stockholder, director or other owner or participant in any business, influence or attempt to influence customers, patients, referral sources,
vendors, suppliers, licensors, lessors, joint venturers, associates, consultants, agents, or partners of the Company Group, either directly or indirectly, to divert their business away from the Company Group, to any individual, partnership, firm,
corporation or other entity then in competition with the business of any entity within the Company Group, and the Executive will not otherwise interfere with, disrupt or attempt to disrupt the business relationships, contractual or otherwise,
between the Company, any of its respective affiliates or subsidiaries, and any customers, suppliers, vendors, lessors, licensors, joint venturers, associates, officers, employees, consultants, managers, partners, members of or investors in any
entity within the Company Group. 
 (b) During the term of the Executive’s employment with the Company and
during the Post-Termination Period, the Executive will not on behalf of any individual or entity (other than the Company Group) directly or indirectly (i) induce, encourage or otherwise solicit (or assist in soliciting) any person who is an
employee, independent contractor, consultant or business partner of any entity within the Company Group to terminate his, her or its employment relationship, contract, consulting relationship or partnership arrangement with such entity to accept any
other employment or position; or (ii) assist any other entity in hiring any such employee, independent contractor, consultant or business partner. 
  

 3 

 4. Cooperation; Nondisparagement. The Executive agrees that, following termination of
employment with the Company, the Executive will cooperate, at no financial cost to the Executive, with any reasonable request the Company may make for information or assistance with respect to any matter involving the Executive. Furthermore, the
Executive shall at no time make any libelous or slanderous remarks or writings about any entity within the Company Group, or any such entity’s officers or directors. 

5. Company Remedies. In the event that the Company, acting in good faith and based on its reasonable belief at the time,
determines that the Executive has engaged in Detrimental Activity, the Company shall have the right to take any or all of the actions set forth in this Section 5 to the fullest extent not prohibited by law; provided, however, that in the case of
Detrimental Activity described in clause (i) of the definition of the term Detrimental Activity as set forth below, the Company shall have the right to take any or all of the actions set forth in Sections 5(a) and 5(b) (but, for purposes of clarity,
shall not have the ability to take any of the actions set forth in Sections 5(c) and 5(d) with respect to such nature of Detrimental Activity). For purposes of this Agreement, “Detrimental Activity” shall mean (i) a breach of any of the
covenants set forth in Sections 1 through 4 above that has resulted in material and demonstrable injury, monetarily or otherwise, to the Company, (ii) that, as a result of fraud or other misconduct by the Executive, the Company is required to
prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under applicable securities laws, or (iii) Executive is found to have engaged in activities which are in violation of
applicable law and such activities have resulted in material and demonstrable injury, monetarily or otherwise, to the Company. (The date of any determination by the Company that the Executive has engaged in Detrimental Activity is referred to herein
as the “Determination Date.”) For these purposes, a determination by the Company that Detrimental Activity has occurred shall occur when either the Company’s Chairman of the Board of Directors or the Company’s Chief Executive
Officer shall have notified the Company’s General Counsel in writing of its belief that the Executive engaged in Detrimental Activity within the meaning of this Agreement. For purposes of this Agreement, material damage to the Company may
include damage to its reputation or standing before current or potential customers, current or potential sources of patient or customer referrals, industry suppliers, current or potential sources of financing or equity capital, or public or
semi-public regulatory bodies such as the United States Department of Health and Human Services or the Joint Commission on Accreditation of Healthcare Organizations, and such damage need not be demonstrable as pecuniary damage. The parties stipulate
that such damage may be shown in any judicial or arbitration by providing copies of media and analytical reports supported by written affidavit or oral testimony as having been published to the general public or a particular group in addition to any
other form of evidence ordinarily allowed in judicial or arbitration proceedings. 
  

 4 

 (a) Termination of Cash Bonuses. The Company shall have the right to
terminate immediately any and all rights the Executive may have with respect to any cash bonuses or other cash incentive opportunities (“Cash Bonuses”) awarded to the Executive under any Incentive Compensation Plan to the extent such Cash
Bonuses have not been paid as of the Determination Date. 
 (b) Termination of Equity Awards. The Company
shall have the right to terminate immediately any or all (i) stock options granted to the Executive that are outstanding and unexercised (whether or not vested) as of the Determination Date, and/or (ii) other equity-based or cash awards granted or
issued under any Incentive Compensation Plan or Incentive Compensation Agreement to the Executive that are outstanding and unpaid (whether or not vested) as of the Determination Date. 

(c) Company Repurchase Option. 

(i) The Company shall have the right to repurchase any shares of the Company’s common stock (“Common
Stock”) acquired by the Executive during the [one-year] period preceding the Determination Date pursuant to either (A) the exercise of any stock option granted by the Company to the Executive (whether granted on, before or after the date of
this Agreement) or (B) the vesting or payment of any restricted stock, restricted stock unit or other equity-based award granted by the Company under any Incentive Compensation Agreement or Plan to the Executive whether granted on, before or after
the date of this Agreement) (the “Repurchase Right”). The per-share price of any such repurchase of shares by the Company shall be equal to the lesser of (x) the Fair Market Value of the Common Stock at the time the Company gives
notice of its intention to repurchase such shares, or (y) the per-share price paid by the Executive for such shares in connection with such exercise or vesting or payment event. For purposes of this Agreement, “Fair Market Value” shall be
determined in accordance with the Company’s 2003 Performance Incentive Plan as in effect on the Effective Date. For purposes of clarity, the repurchase price for such shares shall be zero if the Executive did not pay any cash amount to acquire
such shares. 
 (ii) The closing of any repurchase of shares following the Company’s exercise of its
Repurchase Right shall be at a date specified by the Corporation in the Detrimental Activity Notice (as defined below), such date to be no later than 30 days after the date of the Detrimental Activity Notice. The purchase price (if any) shall be
paid at the closing in the form of a check against surrender by the Executive of a stock certificate evidencing the repurchased shares with duly endorsed stock powers, free of adverse claims. No adjustments (other than as provided in the applicable
stock incentive plan and/or award agreement) shall be made to the purchase price for fluctuations in the Fair Market Value of the shares after the date of the Detrimental Activity Notice. The Executive shall represent to the Company that the shares
are not subject to any lien, encumbrance, pledge, or other interest of a third party. The Executive may not sell, encumber, pledge or otherwise transfer or alienate any of the shares after the date of the Detrimental Activity Notice. The Company
shall have the right, to the maximum extent permitted by law, to offset against any payment otherwise due from the Executive any amount the Company is required to pay to the Executive in accordance with this Section 5. 

 

 5 

 (d) Company Cash Reimbursement Right. 

(i) In the event that all or a portion of any of the shares of Common Stock referred to in the first sentence of Section
5(c) are not then owned by the Executive without restriction (for this purpose, the shares will be considered “restricted” if they are subject to, without limitation, any lien, encumbrance, pledge or other interest of a third party), the
Company shall have the right to require the Executive to pay to the Company an amount equal to (x) the total number of shares acquired by the Executive on such option exercise, multiplied by (y) the difference between (A) the greater of the Fair
Market Value of the Common Stock on [the date of the Detrimental Activity Notice] or the per-share consideration received by the Executive in any sale or other transfer or all or a portion of such shares, and (B) the per-share price (if any) paid by
the Executive for such shares in connection with such exercise or vesting or payment event (the “Cash Reimbursement Right”). 

(ii) Any payment required to be made by the Executive to the Company following the Company’s exercise of its Cash
Reimbursement Right shall (a) be paid in the form of a certified or cashier’s check payable to the order of the Company, and (b) be delivered no later than 30 days after the date of the Detrimental Activity Notice to the Company at the address
of its principal executive offices to the attention of the Company’s Chief Executive Officer, such delivery to be made by postage pre-paid registered or certified U.S. Mail. The Company shall have the right, to the maximum extent permitted by
law, to offset against any payment otherwise due to the Executive any amounts the Executive is required to pay to the Company in accordance with this Section 5. 

(e) Exercise of Company’s Rights. The Company’s exercise of any of its rights under the provisions of
this Section 5 shall be exercisable by the Company by delivery of a written notice to the Executive (the “Detrimental Activity Notice”), which notice must set forth the general basis of the Company’s finding of Detrimental Activity,
be mailed to the attention of or otherwise actually delivered to the Executive at the Executive’s most recent address reflected in the Company’s payroll records, and be so mailed or delivered during the Exercise Period set forth below. The
“Exercise Period” shall commence on the Determination Date and shall terminate on the date that is sixty days after the Determination Date. The Company shall have the right to exercise any or all rights or remedies provided for in this
Agreement at its sole discretion and the fact that the Company shall fail or defer its rights to exercise such rights or remedies in any given situation shall not preclude the Company from exercising such rights or remedies in any other situation
even if such situation is identical or similar to the situation in which the Company declined to exercise such rights or remedies. All remedies provided herein are cumulative and are in addition to and not in limitation of any other remedies
available at law, in equity or by contract. The pursuit of any one remedy shall not be deemed to limit the right to pursue any other remedy, except to the extent that such remedy has been fully realized in am manner that excludes the possibility of
pursuing the other remedy. 
  

 6 

 6. Agreement to Compensate the Executive. 

(a) Payment. The parties agree that, in the event that within the period that (i) begins with the first to occur of
(1) the initial public announcement of a Change of Control (as defined in the Employment Agreement), or (2) the 90th day preceding a Change of Control and (ii) ends two years following such Change of Control, the Executive’s employment is
terminated by the Company for any reason other than disability or Cause (as defined in the Employment Agreement), or in the event that the Executive terminates his employment with the Company with Good Reason (as defined in the Employment Agreement)
during said period, the Executive shall be entitled to receive payments that equal $750,000 in the aggregate, it being understood that (A) such payments are intended to compensate the Executive fully for the performance of the Executive’s
covenants set forth in Sections 1 through 4 above during the Post- Termination Period, and (B) the Executive is not entitled to receive any payments under this Section 6 in the event the Executive’s employment is terminated other than under one
of the circumstances described in this Section 6(a). 
 (b) Timing of Payment. The payment payable to the
Executive pursuant to Section 6(a) above shall be divided into thirteen (13) equal installments and paid biweekly over the twenty-six (26)-week period beginning on the first business day that is six months after the termination of the
Executive’s employment with the Company; provided, however, that if any such payment date is not a business day, payment shall be delayed until the next following business day. 

(c) Termination of Payments. The Executive expressly acknowledges and agrees that his right to continue to receive
the payments hereunder is subject to his continued compliance with the restrictive covenants set forth in Sections 1 through 4 of this Agreement. If the Company determines that the Executive is in violation of any of the provisions of such
restrictive covenants, then the Company, following written notice to the Executive explaining the basis for its decision, may, except as provided in Section 7(a) below, suspend any future payments scheduled to be made pursuant to this Section 6;
provided, however, that: 
 (i) the burden of proving that the Executive is in violation of any of the
restrictive covenants set forth in Sections 1 through 4 of this Agreement shall be on the Company; 
 (ii) the
Company shall pay all expenses incurred by the Executive in prosecuting or defending any proceeding pursuant to Section 7(a) hereof with regard to such determination by the Company as they are incurred by the Executive in advance of the final
disposition of such proceedings, together with any tax liability incurred by the Executive in connection with the receipt of such amounts; provided, however, that the payment of such expenses incurred in advance of the final disposition of such
proceeding shall be made only upon delivery to the Company of an undertaking, by or on behalf of the Executive, to repay all amounts so advanced to the extent the arbitrator in such proceeding affirmatively determines that the Company is the
prevailing party, taking into account all claims made by any such party to such proceeding; and 
  

 7 

 (iii) all payments described in Section 6 of this Agreement shall continue
to be made or provided on the dates provided herein as if no such violation exists, except in the event a final determination pursuant to the arbitration provisions of Section 7(a) has been rendered and such determination provides that the Executive
is, in fact, in violation of any of the restrictive covenants set forth in Sections 1 through 4 of this Agreement. 
 In order to
implement the principle of this Section 6(c), in the event that an arbitrator determines that the Executive has violated any of the provisions of Sections 1 through 4 of this Agreement, the arbitrator may require that the Executive return to the
Company any amounts paid to the Executive pursuant to Section 6(c)(iii) following the date of such violation. 

(d) Term. This Section 6, and the Executive’s right to receive payments hereunder, shall have an initial term
(the “Term”) of two years and shall terminate and be of no further force or effect on the second anniversary of the Effective Date; provided, however, that commencing on the second anniversary of the Effective Date and on each anniversary
thereafter (each an “Extension Date”), the Term shall be automatically extended for an additional one-year period, unless the Company provides the Executive with written notice at least 30 days before the next Extension Date that the Term
shall not be so extended. Notwithstanding anything in this Agreement to the contrary, upon the occurrence of a Change of Control, the Term shall automatically be extended until the latest of (i) the second anniversary of the consummation of the
Change of Control or (ii) the expiration of the Post-Termination Period if a termination triggering the payment of the benefits described in this Section 6 occurs during the 24-month period following a Change in Control, or (iii) the expiration of
all of the Company’s and/or any successor’s obligations under this Agreement. 
 7. Miscellaneous. 

(a) Arbitration. Any dispute or controversy arising under or in connection with this Agreement or the
Executive’s employment by the Company shall be settled exclusively by arbitration, conducted before a single neutral arbitrator in accordance with the National Rules for Resolution of Employment Disputes of the American Arbitration Association
(“AAA”) as then in effect. Such arbitration shall be conducted in Orange County, California, and the arbitrator shall be a resident of Orange County, California or of a county contiguous to Orange County, California; provided, however,
that provisional injunctive relief may, but need not, be sought in a court of law or equity in aid of arbitration while arbitration proceedings are pending, and any provisional injunctive relief granted by such court shall remain effective until the
matter is finally determined by the arbitrator. The arbitration shall be administered by AAA pursuant to its Commercial Arbitration Rules. Judgment may be entered on the arbitrator’s award in any court having jurisdiction. 

 

 8 

 The parties acknowledge and agree that they are hereby waiving any rights to
trial by jury in any action, proceeding or counterclaim brought by either of the parties against the other in connection with any matter whatsoever arising out of or in any way connected with any of the matters referenced in the first sentence of
the first paragraph of this Section 7(a). 
 The parties agree that the Company shall be responsible for payment
of the forum costs of any arbitration hereunder, including the arbitrator’s fee. The parties further agree that in any proceeding with respect to such matters, the prevailing party will be entitled to recover its reasonable attorney’s fees
and costs from the non-prevailing party (other than forum costs associated with the arbitration which in any event shall be paid by the Company). 

Without limiting the remedies available to the parties and notwithstanding the foregoing provisions of this Section 7(a),
the Executive and the Company acknowledge that any breach of any of the covenants or provisions contained in Sections 1, 2, 3 or 4 of this Agreement could result in irreparable injury to either of the parties hereto for which there might be no
adequate remedy at law, and that, in the event of such a breach or threat thereof, the non-breaching party shall be entitled to obtain a temporary restraining order and/or a preliminary injunction and a permanent injunction restraining the other
party hereto from engaging in any activities prohibited by any covenant or provision in Sections 1, 2, 3 or 4 of this Agreement or such other equitable relief as may be required to enforce specifically any of such covenants or provisions.

 (b) Successors. 

(i) This Agreement is personal to the Executive and shall not, without the prior written consent of the Company, be
assignable by the Executive. 
 (ii) This Agreement shall inure to the benefit of and be binding upon the
Company, its subsidiaries and its successors and any successor to the Company shall be deemed substituted for the Company under the terms of this Agreement for all purposes. As used herein, “successor” shall include any person, firm,
corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires either a controlling interest in the voting stock of the Company or substantial portion of or the business of the
Company. This Agreement shall be considered to be assigned to any such successor, whether that happens by operation of law, operation of the terms of this Agreement, or otherwise. 

(c) Waiver. No waiver of any breach of any term or provision of this Agreement shall be construed to be, nor shall
be, a waiver of any other breach of this Agreement. No waiver shall be binding unless in writing and signed by the party waiving the breach. 
  

 9 

 (d) Modification. This Agreement may not be amended or modified other
than by a written agreement executed by the Executive and the Company. 
 (e) Severability. It is the
desire and intent of the parties that the provisions of this Agreement shall be enforced to the fullest extent permissible under applicable law. If any provision of this Agreement or any part of any such provision is held under any circumstances to
be invalid or unenforceable by any arbitrator or court of competent jurisdiction, then: (i) such provision or part thereof shall, with respect to such circumstances and in such jurisdiction, be modified by such arbitrator or court to conform to
applicable laws so as to be valid and enforceable to the fullest possible extent; (ii) the invalidity or unenforceability of such provision or part thereof under such circumstances and in such jurisdiction shall not affect the validity or
enforceability of such provision or part thereof under any other circumstances or in any other jurisdiction; (iii) the invalidity or unenforceability of such provision or part thereof shall not affect the validity or enforceability of the remainder
of such provision or the validity or enforceability of any other provision of this Agreement. Each provision of this Agreement is separable from every other provision of this Agreement, and each part of each provision of this Agreement is separable
from every other part of such provision. 
 (f) Complete Agreement. This Agreement (together with such
provisions of the Severance Agreement as are necessary to give effect to Section 6 hereof) constitutes and contains the entire agreement and final understanding concerning the subject matters addressed herein between the parties. This Agreement is
intended by the parties as a complete and exclusive statement of the terms of their agreement. It supersedes and replaces all prior negotiations and all agreements proposed or otherwise, whether written or oral, concerning the subject matter hereof.
Any representation, promise or agreement not specifically included in this Agreement shall not be binding upon or enforceable against either party. This Agreement constitutes a fully integrated agreement. 

(g) Governing Law. This Agreement shall be deemed to have been executed and delivered in the State of California,
which is the State in which the Executive is principally employed by the Company as of the date of this Agreement, and the rights and obligations of the parties hereunder shall be construed and enforced in accordance with, and governed by, by the
laws of that particular State without regard to principles of conflict of laws. 
 (h) Construction. In
any construction to be made of this Agreement, the same shall not be construed against any party on the basis that the party was the drafter. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect.

 (i) Communications. All notices, requests, demands and other communications hereunder shall be in
writing and shall be deemed to have been duly given if delivered by hand or by courier, or if mailed by registered or certified mail, postage prepaid, addressed to the Executive at the Executive’s most recent address on record with the Company,
or addressed to the Company at 26220 Enterprise Court, Lake Forest, CA 92630, Attention: General Counsel, with a copy to the attention of the Senior Vice President, Human Resources. Either party may change the address at which notice shall be given
by written notice given in the above manner. 
  

 10 

 (j) Execution. This Agreement may be executed in one or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written. 

 

							
	 APRIA HEALTHCARE GROUP INC.
	  		 	EXECUTIVE
				
	 By
	 	 /s/ Lawrence M. Higby
	  		 	 /s/ Chris A. Karkenny

		 	Lawrence M. Higby	  		 	Chris A. Karkenny
		 	Chief Executive Officer	  		 	

  

 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}]]